# Endomag

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/endomag

- Industry: Medical Devices & Equipment
- Headquarters: Cambridge, UK
- Website: www.endomag.com
- Total disclosed funding: $37M
- Latest round: Series D (Nov 24, 2020)
- Investors on record: 5

## About

Founded in 2007 and based in Cambridge, UK, Endomagnetics Limited, trading under the name Endomag, operates as a developer of magnetic surgical instruments that help minimally invasive procedures for cancer treatments. The company also manufactures dental instruments. The company was established as a result of collaborative research at the University College London (UCL) and the University of Houston. Since its inception, Endomag has expanded its reach globally, with its products being utilized by over 1,350 hospitals across more than 45 countries, spanning six continents. In January 2024, Hologic, Inc. agreed to acquire Endomagnetics Ltd. from Bloomsbury Bioseed Fund, Sussex Place Ventures, New Wave Ventures, Sarum Partners, UCL Business plc, and Molten Ventures for USD 310 million.

Endomag has developed a range of technologies aimed at solving problems in breast cancer surgery. Their flagship product, the Sentimag surgical guidance platform, stands as a testament to their dedication to improving patient outcomes. Endomag's other products, including MagseedPro, Magseed, and Magtrace, provide physicians with tools for precise and less invasive surgical interventions. These technologies have been instrumental in aiding the identification and removal of breast cancer.

Endomag's revenue stream primarily stems from the adoption of its technologies by hospitals globally.

## Funding rounds

- Series D, Nov 24, 2020, $20M — Molten Ventures, Sussex Place Ventures
- Series C, Jul 13, 2018, $10M — Molten Ventures
- Series B, Jul 16, 2013, $3.1M — Sussex Place Ventures, Sarum Partners
- Series A, Sep 27, 2011, $1.1M — New Wave Ventures
- Series A, Aug 5, 2011, $1.9M — Bloomsbury Bioseed Fund, Sussex Place Ventures

## Investors

- Bloomsbury Bioseed Fund (https://capitalatlas.ai/funds/bloomsbury-bioseed-fund) — Series A
- Sussex Place Ventures (https://capitalatlas.ai/funds/sussex-place-ventures) — Series A, Series B, Series D
- New Wave Ventures (https://capitalatlas.ai/funds/new-wave-ventures) — Series A
- Sarum Partners — Series B
- Molten Ventures (https://capitalatlas.ai/funds/molten-ventures) — Series C, Series D